A new class of investigational medicines may help to treat patients with cancers driven by mutations in genes such as BRAF or KRAS/NRAS, including those patients who have become resistant to therapies that target BRAF directly, ...
not rated yet |
0
Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers ...
not rated yet |
0
Vienna, Austria: Identifying an individual's the smoking history could help doctors to predict survival time in people with COPD.
not rated yet |
0
(Medical Xpress) -- The global financial crisis has contributed to an increase in the rates of suicide and attempted suicide for economic reasons in Italy, new research shows.
not rated yet |
1
Results from a retrospective analysis of contemporary data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, predict, based on estimates from a multivariate regression model, that ...
not rated yet |
0
